THE OUTCOME OF IMMUNE THROMBOCYTOPENIC PURPURA IN CHILDHOOD AND THE RISK FACTORS FOR CHRONICITY
Objective: Immune thrombocytopenic purpura (ITP) is the most common cause of pediatric thrombocytopenia. It is usually a self-limiting disease; however, 20-30% of cases become chronic. In this study, we aimed to investigate pediatric ITP cases’ outcomes and whether there are any factors affecting ch...
Guardado en:
Autores principales: | Barış YILMAZ, Ahmet KOÇ, Ömer DOĞRU, Burcu TUFAN TAŞ, Rabia Emel ŞENAY, Nurşah EKER, Ayşe Gülnur TOKUÇ |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/05bfc6f50a7a4283a7730fc55aded722 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
COVID-19 and thrombotic thrombocytopenic purpura: A review of literature
por: Balraj Singh, et al.
Publicado: (2021) -
INTEGRATED EFFICACY RESULTS FROM THE PHASE 2 AND PHASE 3 STUDIES WITH CAPLACIZUMAB IN PATIENTS WITH ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA
por: Flora Peyvandi, et al.
Publicado: (2021) -
EPIDEMIOLOGY, TREATMENT PATTERNS, AND CLINICAL OUTCOMES AMONG PATIENTS WITH ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA (ATTP) IN THE UNITED STATES: AN ELECTRONIC HEALTH RECORDS ANALYSIS
por: Ayoade Adeyemi, et al.
Publicado: (2021) -
CHILDHOOD IMMUNE THROMBOCYTOPENIA: A MULTICENTER QUESTIONNAIRE STUDY
por: Ayşegül Ünüvar, et al.
Publicado: (2021) -
CAVITARY PRIMARY PULMONARY LYMPHOPLASMOCYTIC LYMPHOMA COMPLICATING HENOCH–SCHÖNLEIN PURPURA
por: Burak GULTEKIN, et al.
Publicado: (2021)